Artículo
Management of Kidney Failure in Patients with Diabetes Mellitus: What Are the Best Options?
Autor/es | Buades, Juan M.
Craver, Lourdes Pino, María Dolores del Prieto-Velasco, Mario Ruiz, Juan C. Salgueira Lazo, Mercedes Sequera, Patricia de Vega, Nicanor |
Departamento | Universidad de Sevilla. Departamento de Medicina |
Fecha de publicación | 2021-06-30 |
Fecha de depósito | 2022-09-27 |
Publicado en |
|
Resumen | Diabetic kidney disease (DKD) is the most frequent cause of kidney failure (KF). There
are large variations in the incidence rates of kidney replacement therapy (KRT). Late referral to
nephrology services has been ... Diabetic kidney disease (DKD) is the most frequent cause of kidney failure (KF). There are large variations in the incidence rates of kidney replacement therapy (KRT). Late referral to nephrology services has been associated with an increased risk of adverse outcomes. In many countries, when patients reach severely reduced glomerular filtration rate (GFR), they are managed by multidisciplinary teams led by nephrologists. In these clinics, efforts will continue to halt chronic kidney disease (CKD) progression and to prevent cardiovascular mortality and morbidity. In patients with diabetes and severely reduced GFR and KF, treating hyperglycemia is a challenge, since some drugs are contraindicated and most of them require dose adjustments. Even more, a decision-making process will help in deciding whether the patient would prefer comprehensive conservative care or KRT. On many occasions, this decision will be conditioned by diabetes mellitus itself. Effective education should cover the necessary information for the patient and family to answer these questions: 1. Should I go for KRT or not? 2. If the answer is KRT, dialysis and/or transplantation? 3. Dialysis at home or in center? 4. If dialysis at home, peritoneal dialysis or home hemodialysis? 5. If transplantation is desired, discuss the options of whether the donation would be from a living or deceased donor. This review addresses the determinant factors with an impact on DKD, aiming to shed light on the specific needs that arise in the management and recommendations on how to achieve a comprehensive approach to the diabetic patient with chronic kidney disease. |
Cita | Buades, J.M., Craver, L., Pino, M.D.d., Prieto-Velasco, M., Ruiz, J.C., Salgueira Lazo, M.,...,Vega, N. (2021). Management of Kidney Failure in Patients with Diabetes Mellitus: What Are the Best Options?. Journal of clinical medicine, 10 (13), 2943. https://doi.org/10.3390/jcm10132943. |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
Management of Kidney Failure in ... | 822.0Kb | [PDF] | Ver/ | |
Este registro aparece en las siguientes colecciones
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Items relacionados
Enseñando items relacionados por título, autor, creador y materia.
-
Artículo
Years of potential life lost on renal replacement therapy: retrospective study cohort
Muñoz Terol, José Manuel; Rocha Castilla, José Luis; Castro-de la Nuez, Pablo; García Cabrera, Emilio; Vilches Arenas, Ángel (MDPI, 2023)Chronic kidney disease is the non-communicable disease with the highest growth in morbidity and mortality. Renal ...
-
Artículo
IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy
Trujillo, H.; Sandino, J.; Cavero, Teresa; Caravaca-Fontan, F; Gutierrez, E.; Sevillano, A.M.; Muñoz Terol, José Manuel; Praga, Manuel (Elsevier, 2022-01-19)Introduction Anticoagulant-related nephropathy (ARN) is a relatively novel recognized entity characterized by ...
-
Artículo
The ERA-EDTA Registry Annual Report 2018: a summary
Borroni, Davide; Boenink, R; Stel, VS; de Pablos, CS; Tomovic, F; Golan, E; Muñoz Terol, José Manuel; Jager, KJ (Oxford University Press, 2021)Background The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry collects ...